510(k) device
Highly Cross Linked Ve Central Peg Patella Highly Cross Linked Ve Tri-Peg Patella Highly Cross Linked Ve Metal Backed Pa
Encore Medical L.P. · Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive (OIY, Class II) · First FDA decision Mar 14, 2012, newest Mar 14, 2012Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
67
Naming "Highly Cross Linked"
MAUDE reports
48
Brand "Highly Cross Linked", since 2015
PubMed studies
1,579
Mentioning "Highly Cross Linked"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Highly Cross Linked Ve Central Peg Patella Highly Cross Linked Ve Tri-Peg Patella Highly Cross Linked Ve Metal Backed Pa
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K113756 · Decided Mar 14, 2012 · 84 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive (OIY) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Highly Cross Linked", any status and sponsor, newest update first.
- A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision ReconstructionActive, not recruiting
Mentor Worldwide, LLCNot on our public-company list
NCT02724371 · 400 participants · Start Apr 1, 2016 · Primary completion Jan 31, 2029
Device: Mentor Larger Size MemoryGel Ultra High Profile Breast Implant · For: Breast Reconstruction; Revision Breast Reconstruction
Sites: Montgomery, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 30 sites in all
- Longterm-Evaluation of Vitelene® Against StandardActive, not recruiting
Aesculap AGNot on our public-company list
NCT01713062 · 400 participants · Start Jan 2012 · Primary completion Apr 2027
Device: Vitelene; XLPE · For: Osteoarthritis, Hip; Arthritis
Sites: Bendorf, Germany; Bochum, Germany; Halle, Germany · 6 sites in all
Uppsala UniversityAcademic, hospital or other
NCT07863557 · 40 participants (planned) · Start Oct 8, 2026 · Primary completion Oct 1, 2033
Device: Total Hip Arthroplasty · For: Osteoarthritis; Osteonecrosis; Dysplasia; Hip
Sites: Uppsala, Sweden
Cyprus Health and Social Sciences UniversityAcademic, hospital or other
NCT07853196 · 45 participants · Start Mar 5, 2026 · Primary completion Jul 25, 2026
Device: Absorbable Hemostatic Gelatin Sponge (SPONGOSTAN™ Dental) · For: Postoperative Morbidity
Sites: Mórfou, Cyprus
- F-GYN for Vaginal Dryness and Vulvovaginal AtrophyPivotal-lookingRecruiting
Biovico Sp. z o.o.Not on our public-company list
NCT07701863 · 130 participants (planned) · Start Jul 24, 2026 · Primary completion Aug 2027
Device: F-GYN Non-Crosslinked Hyaluronic Acid Injectable Gel · For: Atrophic Vaginitis; Atrophic Vulvovaginitis; Vaginal Atrophy and 3 more
Sites: Bolesławice, Poland; Elblag, Poland; Gdansk, Poland
- Safety and Effectiveness of the HIT Reverse HRSPivotal-lookingRecruiting
Hip Innovation TechnologyNot on our public-company list
NCT05357378 · 288 participants (planned) · Start Jul 15, 2022 · Primary completion Sep 16, 2030
Device: Hip Innovation Technology Reverse Hip Replacement System; Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. · For: Degenerative Joint Disease; Osteoarthritis, Hip; Avascular Necrosis of Hip and 1 more
Sites: Miami, Florida; Tampa, Florida; Baltimore, Maryland · 6 sites in all
IntervascularNot on our public-company list
NCT07322913 · 1,200 participants (planned) · Start Dec 19, 2025 · Primary completion Jul 2027
Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches; Hemashield - Collagen Coated Vascular Grafts and Patches and 2 more · For: Carotid Artery Diseases; Aortic Diseases; Peripheral Arterial Diseases
Sites: Hershey, Pennsylvania; Pittsburgh, Pennsylvania; Leuven, Belgium · 5 sites in all
- Randomized Assessor-Masked Trial of Moderate Graduated Compression Stockings for Popliteal Vein Dilation During Long-Haul Economy-Class Air Travel After Aesthetic SurgeryPivotal-lookingRecruiting
Research IncNot on our public-company list
NCT07810192 · 160 participants (planned) · Start Jan 1, 2024 · Primary completion Sep 1, 2026
Device: Knee-High Graduated Compression Stockings · For: Physiologic Venous Dilation; Air Travel
Sites: Bogotá, Colombia
Research IncNot on our public-company list
NCT07808931 · 200 participants (planned) · Start Jan 12, 2024 · Primary completion Sep 1, 2026
Device: Knee-High Graduated Compression Stockings · For: Physiologic Venous Dilation; Air Travel
Sites: Bogotá, Colombia
Zimmer BiometPublic (ZBH)
NCT03226808 · 245 participants · Start Oct 1, 2013 · Primary completion Apr 14, 2026
Device: Vivacit-E Liner · For: Osteoarthritis; Avascular Necrosis of Bone of Hip; Post-traumatic; Arthrosis and 1 more
Sites: Parker, Colorado; Chapel Hill, North Carolina; Charlotte, North Carolina · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Highly Cross Linked", and for the whole product code for context.
This brand
48 reports: 0 malfunction, 46 injury, 2 death
Whole product code OIY
1,332 reports: 123 malfunction, 1,204 injury, 0 death
Newest reports for this brand
0001822565-2026-01992 · Received Jun 19, 2026 · Event dated May 6, 2026
Device type: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer (MBH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Joint Laxity
1020279-2025-01542 · Received Sep 16, 2025 · Event dated Aug 20, 2025
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH)
Device problem as coded: Fracture
Patient problem as coded: Insufficient Information
0009613350-2025-00269 · Received Apr 9, 2025
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented (LZO)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Joint Dislocation
0009613350-2025-00230 · Received Apr 7, 2025
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented (LZO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Insufficient Information
1020279-2025-00469 · Received Mar 12, 2025 · Event dated Feb 21, 2025
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH)
Device problem as coded: Fracture
Patient problem as coded: Subluxation; Joint Laxity
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0626-2024 · Started Oct 5, 2023 · Posted by FDA Jan 2, 2024
Reason given: Mislabeling
Cause as FDA categorized it: Packaging process control · Device type: Shoulder Prosthesis, Reverse Configuration (PHX)
Published research
The most relevant PubMed records for "Highly Cross Linked"[tiab]. The summary above synthesizes these.
- Highly cross-linked carbon tube aerogels with enhanced elasticity and fatigue resistance.
Zhuang L, Lu D, Zhang J, et al. · Nat Commun · 2023
- Computational indentation in highly cross-linked polymer networks.
Maurya MK, Ruscher C, Mukherji D, et al. · Phys Rev E · 2022
- Highly Cross-Linked Polyethylene in Patients 50 Years of Age and Younger: A 20-year Follow-Up Analysis.
Zitsch BP, Cahoy KM, Urban ND, et al. · J Arthroplasty · 2024
- Second-Generation Highly Cross-Linked Polyethylene in Total Hip Arthroplasty.
Parekh A, Sood A, Monsef JB, et al. · JBJS Rev · 2021
- Is Highly Cross-Linked Polyethylene Safe for Use in High-Flexion Posterior Stabilized Total Knee Arthroplasty?
Kim YH, Park JW, Jang YS, et al. · J Arthroplasty · 2023
- Highly Cross-linked Epoxy Coating for Barring Organophosphate Chemical Warfare Agent Permeation.
Wu G, Zhang D, Xu W, et al. · ACS Omega · 2022
- Highly cross-linked polyethylene in primary total knee arthroplasty is associated with a lower rate of revision for aseptic loosening: a meta-analysis of 962,467 cases.
Gkiatas I, Karasavvidis T, Sharma AK, et al. · Arch Orthop Trauma Surg · 2022Meta-Analysis, Review
- Highly cross-linked polyethylene still outperforms conventional polyethylene in THA: 10-year RSA results.
Bergvinsson H, Zampelis V, Sundberg M, et al. · Acta Orthop · 2021Comparative Study
- Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery.
Morales-Burgos AM, Carvajal-Millan E, Sotelo-Cruz N, et al. · Eur J Pharm Biopharm · 2021
- Failure of a Highly Cross-Linked Polyethylene Liner After Spine Fusion.
Roesler K, Garvin KL · J Am Acad Orthop Surg Glob Res Rev · 2023Case Reports
- Thin highly cross-linked polyethylene liners combined with large femoral heads in primary total hip arthroplasty show excellent survival and low wear rates at a mean follow-up of 12.8 years.
Fransen BL, Bengoa FJ, Neufeld ME, et al. · Bone Joint J · 2023
- Comparative Study of Highly Cross-Linked Polyethylene Liner Wear by Hip Center Location Using Elevated Hip Center Technique in Crowe I to III Hip Dysplasia: Outcomes for a Minimum of Eighteen Years of Follow-Up.
Takahashi E, Chen M, Kaneuji A, et al. · J Arthroplasty · 2023
Other devices of this type
Also filed under product code OIY.
- DePuy ATTUNE Knee SystemDePuy Orthopaedics, Inc. · 510(k) 2026
- Highly Cross-Linked Vitamin E Uhmwpe Tibial InsertsEncore Medical L.P. · 510(k) 2010
- DePuy ATTUNE Total Knee SystemDepuy Orthopedics, Inc. · 510(k) 2024
- A200 Knee SystemRenovis Surgical Technologies, LLC · 510(k) 2013
- Movation Knee SystemEncore Medical L.P. · 510(k) 2012
- Depuy Sttune (Tm) Ps Knee SystemDePuy Orthopaedics, Inc. · 510(k) 2011
- E1 Antioxidant Infused TechnologyBiomet Manufacturing Corp · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.